All In Biotech

Free tool

FAERS Monitor: Vumerity

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 211855 or its brand name (Vumerity, Diroximel Fumarate). Reports on generic versions are filed under their own applications.

Reports

12,103

Serious

4,667

39% of reports

Hospitalization

2,344

Death reported

368

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • flushing1,642
  • multiple sclerosis1,122
  • multiple sclerosis relapse998
  • diarrhoea884
  • product dose omission issue829
  • fatigue795
  • nausea760
  • headache635
  • pruritus603
  • memory impairment581
  • fall571
  • abdominal discomfort532
  • product dose omission in error515
  • drug ineffective510
  • abdominal pain upper477

Reports by year received

View as table
YearReports
20141
20163
20174
20186
201925
2020479
20212,041
20222,568
20232,539
20241,855
20251,638
2026944

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,056 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
multiple sclerosisSignal1,12241.739.443,621
product dose omission in errorSignal51532.229.515,262
flushingSignal1,64228.527.243,069
multiple sclerosis relapseSignal99825.724.223,363
memory impairmentSignal5817.46.83,203
abdominal discomfortSignal5325.55.11,977
product dose omission issueSignal8294.94.62,607
abdominal pain upperSignal4774.03.71,093
fallSignal5713.02.8762
pruritusSignal6032.72.5670
diarrhoeaSignal8842.42.2729
fatigue7951.81.7278
headache6351.81.6214
nausea7601.71.6211
drug ineffective5100.70.686

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.